CVE-2012-2179

Description

libodm.a in IBM AIX 5.3, 6.1, and 7.1 allows local users to overwrite arbitrary files via a symlink attack on a temporary file.

Category

6.9
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.22%
Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.ibm.com/support/docview.wss?uid=isg1IV21382 vendor advisory
http://www.securitytracker.com/id?1027193 vdb entry
http://www.ibm.com/support/docview.wss?uid=isg1IV21381 vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/75510 vdb entry
http://www.ibm.com/support/docview.wss?uid=isg1IV21379 vendor advisory
http://www.ibm.com/support/docview.wss?uid=isg1IV21383 vendor advisory
http://www.ibm.com/support/docview.wss?uid=isg1IV22019 vendor advisory
http://www.osvdb.org/83133 vdb entry
http://aix.software.ibm.com/aix/efixes/security/libodm_advisory.asc patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2012-2179?
CVE-2012-2179 has been scored as a medium severity vulnerability.
How to fix CVE-2012-2179?
To fix CVE-2012-2179, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-2179 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2012-2179 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.